...
机译:miR-564在骨肉瘤中抑制下调,并通过靶向akt抑制骨肉瘤细胞的增殖
Three Gorges Univ Renmin Hosp Dept Orthoped Yichang Hubei Peoples R China;
Three Gorges Univ Renmin Hosp Dept Orthoped Yichang Hubei Peoples R China;
Three Gorges Univ Renmin Hosp Dept Orthoped Yichang Hubei Peoples R China;
Three Gorges Univ Renmin Hosp Dept Orthoped Yichang Hubei Peoples R China;
Three Gorges Univ Renmin Hosp Dept Orthoped Yichang Hubei Peoples R China;
Three Gorges Univ Renmin Hosp Dept Orthoped Yichang Hubei Peoples R China;
Three Gorges Univ Renmin Hosp Dept Orthoped Yichang Hubei Peoples R China;
miR-564; Osteosarcoma; Cell proliferation; Akt; Glucose metabolism;
机译:miR-564在骨肉瘤中抑制下调,并通过靶向akt抑制骨肉瘤细胞的增殖
机译:通过MicroRNA-449A靶向EZH2通过调节PI3K / AKT信号通路和上皮 - 间充质转换来抑制骨肉瘤细胞增殖,侵袭和迁移
机译:MiR-1258的过度表达通过靶向Akt3在骨肉瘤中抑制细胞增殖
机译:姜黄素负载的自组装富含精氨酸的RGD纳米球诱导的MG-63骨肉瘤细胞增殖的选择性抑制。
机译:多靶点受体酪氨酸激酶抑制剂利尼法尼(ABT-869)通过磷酸肌醇3激酶(PI3K)/ AKT依赖性信号传导途径诱导凋亡并抑制白血病细胞的增殖。
机译:MiR-133b在人类骨肉瘤中被下调并抑制骨肉瘤细胞的增殖迁移和侵袭并促进细胞凋亡。
机译:miR-133b在人骨肉瘤中下调并抑制骨肉瘤细胞的增殖,迁移和侵袭,并促进细胞凋亡。